デフォルト表紙
市場調査レポート
商品コード
1039006

体外診断の世界市場 (2019-2025年):市場予測 (タイプ・技術・用途・エンドユーザー別)・地域的展望・用途の潜在性・市場シェア

In-vitro Diagnostics Market Size By Type, By Technology, By Application By End-user, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 160 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.84円
体外診断の世界市場 (2019-2025年):市場予測 (タイプ・技術・用途・エンドユーザー別)・地域的展望・用途の潜在性・市場シェア
出版日: 2021年11月29日
発行: Global Market Insights Inc.
ページ情報: 英文 160 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

体外診断の市場は、世界中で慢性疾患や感染症が増加していることから、2027年にかけて大きな成長が見込まれています。

製品タイプ別では、機器の部門が約4.5%のCAGRで拡大し、大きな利益をもたらすと予測されています。ラボにおける体外診断用機器の需要が高まっており、同部門の成長が見込まれています。また、検査タイプ別では、分子診断の部門が、新型コロナウイルス感染症 (COVID-19) の影響でニーズが高まっていることから、予測期間中に約5.6%のCAGRで成長すると予測されています。

当レポートでは、世界の体外診断の市場を調査し、市場の定義と概要、COVID-19およびその他の市場影響因子の分析、市場規模の推移・予測、製品タイプ・検査タイプ・用途・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

第3章 体外診断産業の考察

  • 産業の分類
  • 産業情勢
  • 産業への影響要因
    • 成長要因
    • 潜在的リスク&課題
  • 成長の可能性
  • COVID-19:影響分析
  • ポーターの分析
  • 競合情勢
  • PESTEL分析

第4章 体外診断市場:製品タイプ別

  • 主要動向
  • 試薬・キット
  • 機器
    • 市場規模・予測:地域別

第5章 体外診断市場:検査タイプ別

  • 主要動向
  • 臨床化学
  • イムノアッセイ/免疫化学
  • 分子診断
  • 血液検査
  • 尿検査
  • その他
    • 市場規模・予測:地域別

第6章 体外診断市場:用途別

  • 主要動向
  • 腫瘍
  • 感染症
  • 糖尿病
  • 心臓病
  • 腎臓
  • 自己免疫疾患
  • 薬物検査/薬理ゲノミクス
  • その他
    • 市場規模・予測:地域別

第7章 体外診断市場:エンドユーザー別

  • 主要動向
  • 病院
  • 診断検査ラボ
  • 学術研究機関
  • その他
    • 市場規模・予測:地域別

第8章 体外診断市場:地域別

  • 主要動向
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第9章 企業プロファイル

  • 戦略ダッシュボード
  • Sysmex
  • F. Hoffmann-La Roche AG
  • Qiagen
  • Danaher
  • DiaSorin
  • Abbott
  • Bio-Rad Laboratories, Inc.
  • Ortho Clinical Diagnostics
  • Becton Dickinson and Company
  • Thermo Fisher Scientific
  • BioMerieux
  • Siemens Healthineers
図表

Data Tables

  • TABLE 1 In vitro diagnostics market industry 360 degree synopsis, 2016 - 2027
  • TABLE 2 In vitro diagnostics market size, 2016-2027 (USD Million)
  • TABLE 3 In vitro diagnostics market size, By product type, 2016-2027 (USD Million)
  • TABLE 4 In vitro diagnostics market size, By test type, 2016-2027 (USD Million)
  • TABLE 5 In vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 6 In vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 7 In vitro diagnostics market size, by region, 2016-2027 (USD Million)
  • TABLE 8 Industry impact forces
  • TABLE 9 Reagents & kits market size, by region, 2016-2027 (USD Million)
  • TABLE 10 Instruments market size, by region, 2016-2027 (USD Million)
  • TABLE 11 Clinical chemistry market size, by region, 2016-2027 (USD Million)
  • TABLE 12 Immunoassay/immunochemistry market size, by region, 2016-2027 (USD Million)
  • TABLE 13 Molecular diagnostics market size, by region, 2016-2027 (USD Million)
  • TABLE 14 Hematology market size, by region, 2016-2027 (USD Million)
  • TABLE 15 Urinalysis market size, by region, 2016-2027 (USD Million)
  • TABLE 16 Others market size, by region, 2016-2027 (USD Million)
  • TABLE 17 Oncology market size, by region, 2016-2027 (USD Million)
  • TABLE 18 Infectious diseases market size, by region, 2016-2027 (USD Million)
  • TABLE 19 Diabetes market size, by region, 2016-2027 (USD Million)
  • TABLE 20 Cardiology market size, by region, 2016-2027 (USD Million)
  • TABLE 21 Nephrology market size, by region, 2016-2027 (USD Million)
  • TABLE 22 Autoimmune diseases market size, by region (USD Million)
  • TABLE 23 Drug testing/ pharmacogenomics market size, by region (USD Million)
  • TABLE 24 Others market size, by region (USD Million)
  • TABLE 25 North America in vitro diagnostics market size, by country, 2016-2027 (USD Million)
  • TABLE 26 North America in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 27 North America in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 28 North America in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 29 North America in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 30 U.S. in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 31 U.S. in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 32 U.S. in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 33 U.S. in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 34 Canada in vitro diagnostics market size, By product type, 2016-2027 (USD Million)
  • TABLE 35 Canada in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 36 Canada in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 37 Canada in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 38 Europe in vitro diagnostics market size, by country, 2016-2027 (USD Million)
  • TABLE 39 Europe in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 40 Europe in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 41 Europe in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 42 Europe in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 43 Germany in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 44 Germany in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 45 Germany in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 46 Germany in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 47 France in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 48 France in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 49 France in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 50 France in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 51 UK in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 52 UK in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 53 UK in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 54 UK in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 55 Italy in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 56 Italy in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 57 Italy in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 58 Italy in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 59 Spain in vitro diagnostics market size, By product type, 2016-2027 (USD Million)
  • TABLE 60 Spain in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 61 Spain in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 62 Spain in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 63 Asia Pacific in vitro diagnostics market size, by country, 2016-2027 (USD Million)
  • TABLE 64 Asia Pacific in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 65 Asia Pacific in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 66 Asia Pacific in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 67 Asia Pacific in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 68 China in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 69 China in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 70 China in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 71 China in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 72 Japan in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 73 Japan in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 74 Japan in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 75 Japan in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 76 India in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 77 India in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 78 India in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 79 India in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 80 South Korea in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 81 South Korea in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 82 South Korea in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 83 South Korea in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 84 Australia in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 85 Australia in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 86 Australia in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 87 Australia in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 88 Latin America in vitro diagnostics market size, by country, 2016-2027 (USD Million)
  • TABLE 89 Latin America in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 90 Latin America in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 91 Latin America in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 92 Latin America in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 93 Brazil in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 94 Brazil in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 95 Brazil in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 96 Brazil in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 97 Mexico in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 98 Mexico in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 99 Mexico in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 100 Mexico in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 101 MEA in vitro diagnostics market size, by country, 2016-2027 (USD Million)
  • TABLE 102 MEA in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 103 MEA in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 104 MEA in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 105 MEA in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 106 Saudi Arabia in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 107 Saudi Arabia in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 108 Saudi Arabia in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 109 Saudi Arabia in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 110 UAE in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 111 UAE in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 112 UAE in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 113 UAE in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)
  • TABLE 114 South Africa in vitro diagnostics market size, by product type, 2016-2027 (USD Million)
  • TABLE 115 South Africa in vitro diagnostics market size, by test type, 2016-2027 (USD Million)
  • TABLE 116 South Africa in vitro diagnostics market size, by application, 2016-2027 (USD Million)
  • TABLE 117 South Africa in vitro diagnostics market size, by end-user, 2016-2027 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Global in vitro diagnostics market size, 2016 - 2027 (USD Million)
  • FIG. 3 Growth potential analysis, by product type
  • FIG. 4 Growth potential analysis, by test type
  • FIG. 5 Growth potential analysis, by application
  • FIG. 6 Growth potential analysis, by end-user
  • FIG. 7 Porter's analysis
  • FIG. 8 Competitive matrix analysis, 2020
  • FIG. 9 PESTEL analysis
  • FIG. 10 Key segment trends, by product type
  • FIG. 11 Key segment trends, by test type
  • FIG. 12 Key segment trends, by application
  • FIG. 13 Key segment trends, by end-user
  • FIG. 14 Key regional trends, by region
  • FIG. 15 Strategy dashboard, 2020
目次
Product Code: 2820

The in vitro diagnostics market is anticipated to record considerable growth by 2027 owing to increasing incidences of chronic and infectious diseases across the globe.

In vitro diagnostic (IVD) tests are performed on samples collected from the human body, such as blood samples, swabs of mucus from the back of the throat or inside the nose from a fingerstick or vein. These tests can detect diseases or other disorders and help monitor a person's overall health to cure, treat, or prevent diseases. Recently, in vitro diagnostics have been an indispensable method of diagnosing and managing COVID-19 viral infections, which has fueled industry adoption during the pandemic.

Notably, industry players have been adopting profitable strategies to accommodate the mounting demand for IVD tests in view of the ongoing COVID-19 pandemic, thereby enhancing the global business scenario. For instance, in July 2021, DiaSorin S.p.A., a major diagnostics company, completed the acquisition of Luminex Corporation, a leading biotechnology company. The deal enabled DiaSorin to expand its business by leveraging Luminex's existing offerings and multiplexing technology.

The in vitro diagnostics market has been divided on the basis of end-user, product type, application, test type, and region. With respect to product type, the market has further been segregated into instruments and reagents & kits.

The instruments sub-segment is projected to amass considerable gains by 2027, expanding at a CAGR of about 4.5% over the review period. Escalating demand for in-vitro diagnostic instruments in laboratories is likely to foster segmental growth through the study timeline.

Based on test type, the in vitro diagnostics market has been categorized into urinalysis, clinical chemistry, hematology, immunoassay/immunochemistry, molecular diagnostics, and others. The molecular diagnostics sub-segment is slated to progress at around 5.6% CAGR over the forecast period owing to surging need for molecular diagnostics tests during the COVID-19 pandemic.

From the viewpoint of application, the market has been segmented into drug testing/ pharmacogenomics, oncology, autoimmune diseases, infectious diseases, nephrology, diabetes, cardiology, and others. The in vitro diagnostics market from the infectious diseases sub-segment surpassed a valuation of USD 18 billion in 2020 and is expected to witness robust expansion over 2021-2027. Rising prevalence of infectious diseases would create huge demand for IVD tests, which is estimated to augment segmental growth in the upcoming years.

In terms of end-user, the in vitro diagnostics market has been classified into academic & research institutes, hospitals, diagnostic laboratories, and others. In 2020, the hospitals sub-segment held around 40% market share and is speculated to showcase significant progress over the analysis timeline. Soaring availability of trained medical professionals and advanced diagnostic tools is set to propel segmental expansion.

From the regional perspective, the Latin America in vitro diagnostics market was valued at over USD 6 billion in 2020 and is poised to grow at a substantial pace through the assessment timeframe. The developing medical infrastructure, coupled with increasing demand for in vitro diagnostics in LATAM, is likely to drive regional market expansion.

Table of Contents

Chapter 1 Methodology

  • 1.1 Methodology
  • 1.2 Market definitions
  • 1.3 Forecast parameters
  • 1.4 Data sources
    • 1.4.1 Secondary
      • 1.4.1.1 Paid sources
      • 1.4.1.2 Unpaid sources
    • 1.4.2 Primary

Chapter 2 Executive Summary

  • 2.1 In vitro diagnostics industry 360 degree synopsis, 2016 - 2027
    • 2.1.1 Business trends
    • 2.1.2 Product type trends
    • 2.1.3 Test type trends
    • 2.1.4 Application trends
    • 2.1.5 End-user trends
    • 2.1.6 Regional trends

Chapter 3 In Vitro Diagnostics Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2016 - 2027
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Rising prevalence of infectious and chronic diseases
      • 3.3.1.2 Growing adoption of personalized medicine
      • 3.3.1.3 Increasing adoption of point of care testing
      • 3.3.1.4 Surging number of pathology labs and services equipped with advanced diagnostics machine
    • 3.3.2 Industry pitfalls and challenges
      • 3.3.2.1 High cost of diagnostic services
      • 3.3.2.2 Unfavorable reimbursement scenario
  • 3.4 Growth potential analysis
    • 3.4.1 By product type
    • 3.4.2 By test type
    • 3.4.3 By application
    • 3.4.4 By end-user
  • 3.5 COVID-19 impact analysis
  • 3.6 Porter's analysis
  • 3.7 Competitive landscape, 2020
    • 3.7.1 Competitive matrix analysis, 2020
  • 3.8 PESTEL analysis

Chapter 4 In Vitro Diagnostics Market, By Product Type

  • 4.1 Key segment trends
  • 4.2 Reagents & kits
    • 4.2.1 Market size, by region, 2016 - 2027
  • 4.3 Instruments
    • 4.3.1 Market size, by region, 2016 - 2027

Chapter 5 In Vitro Diagnostics Market, By Test Type

  • 5.1 Key segment trends
  • 5.2 Clinical chemistry
    • 5.2.1 Market size, by region, 2016 - 2027
  • 5.3 Immunoassay/immunochemistry
    • 5.3.1 Market size, by region, 2016 - 2027
  • 5.4 Molecular diagnostics
    • 5.4.1 Market size, by region, 2016 - 2027
  • 5.5 Hematology
    • 5.5.1 Market size, by region, 2016 - 2027
  • 5.6 Urinalysis
    • 5.6.1 Market size, by region, 2016 - 2027
  • 5.7 Others
    • 5.7.1 Market size, by region, 2016 - 2027

Chapter 6 In Vitro Diagnostics Market, By Application

  • 6.1 Key segment trends
  • 6.2 Oncology
    • 6.2.1 Market size, by region, 2016 - 2027
  • 6.3 Infectious diseases
    • 6.3.1 Market size, by region, 2016 - 2027
  • 6.4 Diabetes
    • 6.4.1 Market size, by region, 2016 - 2027
  • 6.5 Cardiology
    • 6.5.1 Market size, by region, 2016 - 2027
  • 6.6 Nephrology
    • 6.6.1 Market size, by region, 2016 - 2027
  • 6.7 Autoimmune diseases
    • 6.7.1 Market size, by region, 2016 - 2027
  • 6.8 Drug testing/pharmacogenomics
    • 6.8.1 Market size, by region, 2016 - 2027
  • 6.9 Others
    • 6.9.1 Market size, by region, 2016 - 2027

Chapter 7 In Vitro Diagnostics Market, By End-user

  • 7.1 Key segment trends
  • 7.2 Hospitals
    • 7.2.1 Market size, by region, 2016 - 2027
  • 7.3 Diagnostic laboratories
    • 7.3.1 Market size, by region, 2016 - 2027
  • 7.4 Academic & research institutes
    • 7.4.1 Market size, by region, 2016 - 2027
  • 7.5 Others
    • 7.5.1 Market size, by region, 2016 - 2027

Chapter 8 In Vitro Diagnostics Market, By Region

  • 8.1 Key regional trends
  • 8.2 North America
    • 8.2.1 Market size, by country 2016 - 2027
    • 8.2.2 Market size, by product type, 2016 - 2027
    • 8.2.3 Market size, by test type, 2016 - 2027
    • 8.2.4 Market size, by application, 2016 - 2027
    • 8.2.5 Market size, by end-user, 2016 - 2027
    • 8.2.6 U.S.
      • 8.2.6.1 Market size, By product type, 2016 - 2027
      • 8.2.6.2 Market size, By test type, 2016 - 2027
      • 8.2.6.3 Market size, by application, 2016 - 2027
      • 8.2.6.4 Market size, by end-user, 2016 - 2027
    • 8.2.7 Canada
      • 8.2.7.1 Market size, By product type, 2016 - 2027
      • 8.2.7.2 Market size, By test type, 2016 - 2027
      • 8.2.7.3 Market size, by application, 2016 - 2027
      • 8.2.7.4 Market size, by end-user, 2016 - 2027
  • 8.3 Europe
    • 8.3.1 Market size, by country 2016 - 2027
    • 8.3.2 Market size, by product type, 2016 - 2027
    • 8.3.3 Market size, by test type, 2016 - 2027
    • 8.3.4 Market size, by application, 2016 - 2027
    • 8.3.5 Market size, by end-user, 2016 - 2027
    • 8.3.6 Germany
      • 8.3.6.1 Market size, By product type, 2016 - 2027
      • 8.3.6.2 Market size, By test type, 2016 - 2027
      • 8.3.6.3 Market size, by application, 2016 - 2027
      • 8.3.6.4 Market size, by end-user, 2016 - 2027
    • 8.3.7 France
      • 8.3.7.1 Market size, By product type, 2016 - 2027
      • 8.3.7.2 Market size, By test type, 2016 - 2027
      • 8.3.7.3 Market size, by application, 2016 - 2027
      • 8.3.7.4 Market size, by end-user, 2016 - 2027
    • 8.3.8 UK
      • 8.3.8.1 Market size, By product type, 2016 - 2027
      • 8.3.8.2 Market size, By test type, 2016 - 2027
      • 8.3.8.3 Market size, by application, 2016 - 2027
      • 8.3.8.4 Market size, by end-user, 2016 - 2027
    • 8.3.9 Italy
      • 8.3.9.1 Market size, By product type, 2016 - 2027
      • 8.3.9.2 Market size, By test type, 2016 - 2027
      • 8.3.9.3 Market size, by application, 2016 - 2027
      • 8.3.9.4 Market size, by end-user, 2016 - 2027
    • 8.3.10 Spain
      • 8.3.10.1 Market size, By product type, 2016 - 2027
      • 8.3.10.2 Market size, By test type, 2016 - 2027
      • 8.3.10.3 Market size, by application, 2016 - 2027
      • 8.3.10.4 Market size, by end-user, 2016 - 2027
  • 8.4 Asia Pacific
    • 8.4.1 Market size, by country 2016 - 2027
    • 8.4.2 Market size, by product type, 2016 - 2027
    • 8.4.3 Market size, by test type, 2016 - 2027
    • 8.4.4 Market size, by application, 2016 - 2027
    • 8.4.5 Market size, by end-user, 2016 - 2027
    • 8.4.6 China
      • 8.4.6.1 Market size, By product type, 2016 - 2027
      • 8.4.6.2 Market size, By test type, 2016 - 2027
      • 8.4.6.3 Market size, by application, 2016 - 2027
      • 8.4.6.4 Market size, by end-user, 2016 - 2027
    • 8.4.7 Japan
      • 8.4.7.1 Market size, By product type, 2016 - 2027
      • 8.4.7.2 Market size, By test type, 2016 - 2027
      • 8.4.7.3 Market size, by application, 2016 - 2027
      • 8.4.7.4 Market size, by end-user, 2016 - 2027
    • 8.4.8 India
      • 8.4.8.1 Market size, By product type, 2016 - 2027
      • 8.4.8.2 Market size, By test type, 2016 - 2027
      • 8.4.8.3 Market size, by application, 2016 - 2027
      • 8.4.8.4 Market size, by end-user, 2016 - 2027
    • 8.4.9 South Korea
      • 8.4.9.1 Market size, By product type, 2016 - 2027
      • 8.4.9.2 Market size, By test type, 2016 - 2027
      • 8.4.9.3 Market size, by application, 2016 - 2027
      • 8.4.9.4 Market size, by end-user, 2016 - 2027
    • 8.4.10 Australia
      • 8.4.10.1 Market size, By product type, 2016 - 2027
      • 8.4.10.2 Market size, By test type, 2016 - 2027
      • 8.4.10.3 Market size, by application, 2016 - 2027
      • 8.4.10.4 Market size, by end-user, 2016 - 2027
  • 8.5 Latin America
    • 8.5.1 Market size, by country 2016 - 2027
    • 8.5.2 Market size, By product type, 2016 - 2027
    • 8.5.3 Market size, By test type, 2016 - 2027
    • 8.5.4 Market size, by application, 2016 - 2027
    • 8.5.5 Market size, by end-user, 2016 - 2027
    • 8.5.6 Brazil
      • 8.5.6.1 Market size, By product type, 2016 - 2027
      • 8.5.6.2 Market size, By test type, 2016 - 2027
      • 8.5.6.3 Market size, by application, 2016 - 2027
      • 8.5.6.4 Market size, by end-user, 2016 - 2027
    • 8.5.7 Mexico
      • 8.5.7.1 Market size, By product type, 2016 - 2027
      • 8.5.7.2 Market size, By test type, 2016 - 2027
      • 8.5.7.3 Market size, by application, 2016 - 2027
      • 8.5.7.4 Market size, by end-user, 2016 - 2027
  • 8.6 Middle East and Africa
    • 8.6.1 Market size, by country 2016 - 2027
    • 8.6.2 Market size, By product, 2016 - 2027
    • 8.6.3 Market size, by application, 2016 - 2027
    • 8.6.4 Market size, by end-user, 2016 - 2027
    • 8.6.5 Saudi Arabia
      • 8.6.5.1 Market size, By product type, 2016 - 2027
      • 8.6.5.2 Market size, By test type, 2016 - 2027
      • 8.6.5.3 Market size, by application, 2016 - 2027
      • 8.6.5.4 Market size, by end-user, 2016 - 2027
    • 8.6.6 UAE
      • 8.6.6.1 Market size, By product type, 2016 - 2027
      • 8.6.6.2 Market size, By test type, 2016 - 2027
      • 8.6.6.3 Market size, by application, 2016 - 2027
      • 8.6.6.4 Market size, by end-user, 2016 - 2027
    • 8.6.7 South Africa
      • 8.6.7.1 Market size, by product type, 2016 - 2027
      • 8.6.7.2 Market size, by test type, 2016 - 2027
      • 8.6.7.3 Market size, by application, 2016 - 2027
      • 8.6.7.4 Market size, by end-user, 2016 - 2027

Chapter 9 Company Profiles

  • 9.1 Strategy dashboard, 2020
  • 9.2 Sysmex
    • 9.2.1 Business overview
    • 9.2.2 Financial data
    • 9.2.3 Product landscape
    • 9.2.4 Strategic outlook
    • 9.2.5 SWOT analysis
  • 9.3 F. Hoffmann-La Roche AG
    • 9.3.1 Business overview
    • 9.3.2 Financial data
    • 9.3.3 Product landscape
    • 9.3.4 Strategic outlook
    • 9.3.5 SWOT analysis
  • 9.4 Qiagen
    • 9.4.1 Business overview
    • 9.4.2 Financial data
    • 9.4.3 Product landscape
    • 9.4.4 Strategic outlook
    • 9.4.5 SWOT analysis
  • 9.5 Danaher
    • 9.5.1 Business overview
    • 9.5.2 Financial data
    • 9.5.3 Product landscape
    • 9.5.4 Strategic outlook
    • 9.5.5 SWOT analysis
  • 9.6 DiaSorin
    • 9.6.1 Business overview
    • 9.6.2 Financial data
    • 9.6.3 Product landscape
    • 9.6.4 Strategic outlook
    • 9.6.5 SWOT analysis
  • 9.7 Abbott
    • 9.7.1 Business overview
    • 9.7.2 Financial data
    • 9.7.3 Product landscape
    • 9.7.4 Strategic outlook
    • 9.7.5 SWOT analysis
  • 9.8 Bio-Rad Laboratories, Inc.
    • 9.8.1 Business overview
    • 9.8.2 Financial data
    • 9.8.3 Product landscape
    • 9.8.4 Strategic outlook
    • 9.8.5 SWOT analysis
  • 9.9 Ortho Clinical Diagnostics
    • 9.9.1 Business overview
    • 9.9.2 Financial data
    • 9.9.3 Product landscape
    • 9.9.4 Strategic outlook
    • 9.9.5 SWOT analysis
  • 9.10 Becton Dickinson and Company
    • 9.10.1 Business overview
    • 9.10.2 Financial data
    • 9.10.3 Product landscape
    • 9.10.4 Strategic outlook
    • 9.10.5 SWOT analysis
  • 9.11 Thermo Fisher Scientific
    • 9.11.1 Business overview
    • 9.11.2 Financial data
    • 9.11.3 Product landscape
    • 9.11.4 Strategic outlook
    • 9.11.5 SWOT analysis
  • 9.12 BioMerieux
    • 9.12.1 Business overview
    • 9.12.2 Financial data
    • 9.12.3 Product landscape
    • 9.12.4 Strategic outlook
    • 9.12.5 SWOT analysis
  • 9.13 Siemens Healthineers
    • 9.13.1 Business overview
    • 9.13.2 Financial data
    • 9.13.3 Product landscape
    • 9.13.4 Strategic outlook
    • 9.13.5 SWOT analysis